ERYTHROLEUKAEMIA

This adverse event was reported 76 times

ERYTHROLEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 3 0.0020
1 DISOPYRAMIDE PHOSPHATE 1 0.0012
2 CLADRIBINE 7 0.0007
3 VORINOSTAT 1 0.0005
4 FLUDARABINE PHOSPHATE 14 0.0004
5 AZACITIDINE 10 0.0003
6 PAMIDRONATE DISODIUM 1 0.0003
7 BUSULFAN 4 0.0003
8 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
9 ELOTUZUMAB 1 0.0002
See all drugs enriched for association with ERYTHROLEUKAEMIA